Bringing the power of automation to pharmaceutical manufacturing
- Tweets2.1K
- Following1.5K
- Followers972
- Likes815
ALT Phizzle CMO Ron Ricci and President Ed Lau will conduct a live interview on the strategic value of building process-led technology for the pharmaceutical sector - where regulation and breakthrough innovation must align to make IoT a reality. Between the two of them, Ron and Ed have over six decades of experience creating transformative technologies during notable tenures at companies such as Cisco and Audible. Both Ron and Ed are Phizzle board members as well. Good Manufacturing Practice touches every aspect of pharmaceutical process and regulation. In order to build a viable IOT solution for this heavily monitored space, technology companies have to build software architecture that puts process and data integrity before convenience. This isn’t a simple task and these two experts will explain how an awareness of GMP makes deploying new technologies exponentially smoother at large-scale pharmaceutical companies.
ALT Bad air is dangerous for everyone — and it is the smallest particles that pose the biggest risk to indoor spaces. Airborne diseases like influenza and COVID-19 latch onto these ultrafine particles which can penetrate the lungs and bloodstream more easily. As air quality worsens, the chances of airborne transmission rise. Until recently office managers were not equipped with the correct tools and information to protect from bad air. Today they face a proliferation of air quality technologies. The bad news is that these readings and the devices they pull environmental data from are often unreliable and variable. Many commercially available air sensors exist that claim to capture all sorts of data. Although these claims may have some kernel of truth, the implications of taking action on data pulled from a $19 consumer sensor can be significant.
